Literature DB >> 11076714

Trends in antimicrobial-drug resistance in Japan.

Y Arakawa1, Y Ike, M Nagasawa, N Shibata, Y Doi, K Shibayama, T Yagi, T Kurata.   

Abstract

Multidrug resistance in gram-positive bacteria has become common worldwide. In Japan until recently, gram-negative bacteria such as Pseudomonas aeruginosa, Klebsiella pneumoniae, and Serratia marcescens were controlled by carbapenems, fluoroquinolones, and aminoglycosides. However, several of these microorganisms have recently developed resistance against many antimicrobial drugs.

Entities:  

Mesh：

Year:  2000        PMID： 11076714      PMCID： PMC2640928          DOI： 10.3201/eid0606.000604

Source DB:  PubMed          Journal:  Emerg Infect Dis        ISSN： 1080-6040            Impact factor:   6.883


  26 in total

1.  Salmonella enterica serovar. Typhimurium phage type DT104 and other multi-drug resistant strains in Japan.

Authors:  H Izumiya; K Tamura; J Terajima; H Watanabe
Journal:  Jpn J Infect Dis       Date:  1999-06       Impact factor: 1.362

2.  [Resistance against oral antibiotics to Streptococcus pneumoniae isolated from adult respiratory tract infections].

Authors:  K Matsumoto; T Shiraishi; T Rikimaru; Y Mimori; M Kinoshita; K Oizumi; K Kajimura; S Kondo
Journal:  Kansenshogaku Zasshi       Date:  1999-12

3.  [In vitro activities of 23 antimicrobial agents against 4,993 gram-positive and gram-negative bacterial strains isolated from multicenter of Japan during 1994--in vitro susceptibility surveillance.Levofloxacin-Surveillance Group].

Authors:  K Yamaguchi; A Ohno; F Kashitani; M Iwata; Y Shimizu; S Sato; I Matsumoto; M Itoh; T Funato; Y Tsujio; M Nagasawa; M Tachibana; H Kanno; K Matsuda; J Okada; H Takaya; T Nakamura; J Igari; K Sugimoto; T Oguri; S Toyoshima; M Okada; T Nakai; M Kuwabara; Z Nagasawa
Journal:  Jpn J Antibiot       Date:  1999-02

4.  Antimicrobial resistance of Neisseria gonorrhoeae and high prevalence of ciprofloxacin-resistant isolates in Japan, 1993 to 1998.

Authors:  M Tanaka; H Nakayama; M Haraoka; T Saika
Journal:  J Clin Microbiol       Date:  2000-02       Impact factor: 5.948

5.  A preliminary survey of extended-spectrum beta-lactamases (ESBLs) in clinical isolates of Klebsiella pneumoniae and Escherichia coli in Japan.

Authors:  T Yagi; H Kurokawa; N Shibata; K Shibayama; Y Arakawa
Journal:  FEMS Microbiol Lett       Date:  2000-03-01       Impact factor: 2.742

6.  Glycopeptide-intermediate Staphylococcus aureus: evaluation of a novel screening method and results of a survey of selected U.S. hospitals.

Authors:  S K Hubert; J M Mohammed; S K Fridkin; R P Gaynes; J E McGowan; F C Tenover
Journal:  J Clin Microbiol       Date:  1999-11       Impact factor: 5.948

7.  [Susceptibilities of bacteria isolated from patients with lower respiratory infectious diseases to antibiotics (1997)].

Authors:  H Ikemoto; C Ito; T Yoshida; K Watanabe; T Mori; I Ohno; S Okada; J Igari; M Arakawa; K Igarashi; T Oguri; M Okada; K Ozaki; T Terai; N Aoki; H Inoue; T Nakadate; N Kitamura; O Sekine; Y Suzuki; M Ando; M Suga; K Sato; K Nakata; N Kusano
Journal:  Jpn J Antibiot       Date:  1999-05

8.  New methods of control against postoperative methicillin-resistant Staphylococcus aureus infection.

Authors:  S Kusachi; Y Sumiyama; J Nagao; K Kawai; Y Arima; Y Yoshida; H Kajiwara; Y Saida; Y Nakamura
Journal:  Surg Today       Date:  1999       Impact factor: 2.549

9.  [Outbreak of multidrug-resistant Mycobacterium tuberculosis infection in the middle and advanced age].

Authors:  Y Sasaki; F Yamagishi; F Mizutani; T Yagi; F Kuroda; A Wada
Journal:  Kekkaku       Date:  1999-07

10.  Detection of gyrA mutations among 335 Pseudomonas aeruginosa strains isolated in Japan and their susceptibilities to fluoroquinolones.

Authors:  T Takenouchi; E Sakagawa; M Sugawara
Journal:  Antimicrob Agents Chemother       Date:  1999-02       Impact factor: 5.191
View more
  4 in total

1.  Identification of a Tn1546-like (type 2) element in vancomycin-resistant Enterococcus faecium isolated from hospitalized patients in Japan.

Authors:  R Kariyama; H Kuman; A M Hammerum; F M Aarestrup; L B Jensen
Journal:  Antimicrob Agents Chemother       Date:  2001-03       Impact factor: 5.191

2.  In vitro and in vivo antibacterial activities of SM-216601, a new broad-spectrum parenteral carbapenem.

Authors:  Yutaka Ueda; Katsunori Kanazawa; Ken Eguchi; Koji Takemoto; Yoshiro Eriguchi; Makoto Sunagawa
Journal:  Antimicrob Agents Chemother       Date:  2005-10       Impact factor: 5.191

3.  Escherichia coli producing CTX-M-2 beta-lactamase in cattle, Japan.

Authors:  Yutaka Shiraki; Naohiro Shibata; Yohei Doi; Yoshichika Arakawa
Journal:  Emerg Infect Dis       Date:  2004-01       Impact factor: 6.883

4.  Variability of linezolid concentrations after standard dosing in critically ill patients: a prospective observational study.

Authors:  Michael Zoller; Barbara Maier; Cyrill Hornuss; Christina Neugebauer; Gundula Döbbeler; Dorothea Nagel; Lesca Miriam Holdt; Mathias Bruegel; Thomas Weig; Béatrice Grabein; Lorenz Frey; Daniel Teupser; Michael Vogeser; Johannes Zander
Journal:  Crit Care       Date:  2014-07-10       Impact factor: 9.097
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.